BlackRock Health Sciences Term Trust (NYSE:BMEZ) Short Interest Update

BlackRock Health Sciences Term Trust (NYSE:BMEZ) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 79,800 shares, a drop of 7.4% from the September 30th total of 86,200 shares. Based on an average daily trading volume, of 195,000 shares, the short-interest ratio is currently 0.4 days.

Insider Activity at BlackRock Health Sciences Term Trust

In other news, major shareholder Saba Capital Management, L.P. bought 29,795 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Wednesday, October 16th. The stock was purchased at an average cost of 15.81 per share, with a total value of 471,058.95. Following the completion of the transaction, the insider now directly owns 20,750,913 shares in the company, valued at 328,071,934.53. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Over the last 90 days, insiders purchased 99,630 shares of company stock worth $1,585,113.

Institutional Trading of BlackRock Health Sciences Term Trust

Several institutional investors have recently bought and sold shares of BMEZ. Dakota Wealth Management lifted its holdings in BlackRock Health Sciences Term Trust by 23.4% during the 3rd quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares during the last quarter. Brown Lisle Cummings Inc. increased its holdings in shares of BlackRock Health Sciences Term Trust by 6.2% during the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after buying an additional 2,128 shares in the last quarter. Sanctuary Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the second quarter valued at approximately $3,179,000. Quarry LP boosted its holdings in shares of BlackRock Health Sciences Term Trust by 304.9% in the 2nd quarter. Quarry LP now owns 98,886 shares of the company’s stock worth $1,519,000 after acquiring an additional 74,463 shares in the last quarter. Finally, Almitas Capital LLC grew its position in BlackRock Health Sciences Term Trust by 89.3% during the 2nd quarter. Almitas Capital LLC now owns 1,761,943 shares of the company’s stock worth $27,063,000 after acquiring an additional 831,025 shares during the last quarter.

BlackRock Health Sciences Term Trust Stock Performance

NYSE:BMEZ traded down 0.09 during mid-day trading on Thursday, hitting 15.43. The company’s stock had a trading volume of 227,200 shares, compared to its average volume of 265,695. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59. The stock has a fifty day moving average of 15.83 and a 200-day moving average of 15.49.

BlackRock Health Sciences Term Trust Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Stockholders of record on Tuesday, October 15th will be issued a $0.176 dividend. The ex-dividend date is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.69%.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.